Evidence map›Paper›PMID 40424382›Full record

ArticlePloS one2025

An Interval-valued intuitionistic Fuzzy group decision-making approach based on projection measurement extended VIKOR for patent quality evaluation.

Xiaojun Xie, Saratha Sathasivam, Hong Ma

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaojun XieSchool of General Education, Guangzhou College of Technology and Business, Guangzhou, China.ORCID https://orcid.org/0009-0003-1951-452X
Saratha SathasivamSchool of Mathematical Sciences, Universiti Sains Malaysia (USM), Penang, Malaysia.ORCID https://orcid.org/0000-0002-2843-7082
Hong MaSchool of Mathematical Sciences, Universiti Sains Malaysia (USM), Penang, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patent quality assessment is a multi-attribute decision-making problem. The increasingly complex social environment makes group decision-making based on interval-valued intuitionistic fuzzy (IVIF) information more and more important. In group decision-making, considering using a comprehensive projection measure to calculate the similarity between two decision matrices is one of the important steps. In order to make up for the deficiencies of the classical projection measure and the existing normalized projection measure in measuring the similarity between two IVIF vectors and optimize the group decision-making performance of the VIKOR method, this study proposes: (1) a new definition of subtraction of IVIF numbers, which further enriches the theoretical basis of IVIF numbers; (2) a new normalized projection measure to measure the similarity between two IVIF matrices; (3) combined with the regret matrix to store group regret information, which enhances the comprehensive ability of the classical VIKOR technique, and then establishes a comprehensive GDM method for patent quality assessment. Finally, a specific patent quality assessment example in the existing literature is used for data experiment. Through static and dynamic experimental comparative analysis, the feasibility and effectiveness of the proposed method are illustrated, and it can almost produce a stable ranking. The research in this paper not only provides an effective group decision-making tool for patent quality assessment, but also provides theoretical support and practical guidance for fuzzy group decision-making problems in other fields.

Indexed as

Decision MakingFuzzy LogicPatents as TopicAlgorithmsHumans

Identifiers

PMID40424382
PMCPMC12112242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.